期刊文献+

不同浓度的5-氮杂胞苷对RPMI8226细胞系的诱导凋亡作用分析 被引量:2

Analysis on the Induction of Different Concentrations of 5-Azacytidine to RPMI 8226 Cell Apoptosis
原文传递
导出
摘要 目的:探讨不同浓度的5-氮杂胞苷对RPMI 8226细胞系的诱导凋亡作用。方法:对RPMI 8226细胞系采用5-氮杂胞苷0μmol/L、2μmol/L、5μmol/L、10μmol/L、20μmol/L、50μmol/L处理24 h、48 h、72 h,并对RPMI 8226细胞系处理后进行刮痕实验,12 h后对细胞迁移进行比较。结果:在作用24h、48h时,随着作用浓度的增加,RPMI-8226细胞的抑制率出现明显的增加,但在作用72 h时,我们发现10μmol/L、20μmol/L、50μmol/L其对RPMI-8226细胞的抑制效果无明显的差异性;刮痕实验后12 h后其出现差异性,其中药物浓度越大其对RPMI-8226细胞的运动迁移能力越弱。结论:DNA甲基化转移酶抑制剂5-氮杂胞苷可对RPMI-8226细胞的凋亡具有良好的诱导效果,同时可抑制RPMI-8226细胞的增殖以及迁移。 Objective: To explore the induction of different concentrations of 5-azacytidine to RPMI 8226 cell lines apoptosis.Methods: The RPMI 8226 cell lines were treated by the 5-azacytidine of different concentrations(0 μmol /L,2 μmol /L,5 μmol /L,10 μmol /L,20 μmol /L,50 μmol /L) for 24 h,48 h,72 h.After treatment,the RPMI 8226 cell lines were processed with scratches experiment,then the cell migration was compared at 12 h later.Results: After treated for 24 h or 48 h,RPMI-8226 cell inhibition rate increased significantly along with the increased concentrations,but after 72 h,we found that the 10 μmol /L,20 μmol /L,50 μmol /L of 5-azacytidine had no significant difference in the inhibitory effect on RPMI-8226 cells.12 h after scratches experiment appeared difference,the higher the concentration of the drug,the weaker movement migration capability of RPMI-8226 cells.Conclusion: DNA methyltransferase inhibitor 5-azacytidine had good induction on RPMI-8226 cell apoptosis,and inhibited cell proliferation and migration of RPMI-8226.
出处 《现代生物医学进展》 CAS 2013年第13期2437-2439,2444,共4页 Progress in Modern Biomedicine
关键词 5-氮杂胞苷 RPMI8226细胞系 凋亡 多发性骨髓瘤 5-azacytidine RPMI 8226 cell lines Apoptosis Multiple myeloma
  • 相关文献

参考文献2

二级参考文献45

  • 1Fujita T, Inoue K, Yamamoto S, et al. Fungal metabolites. Partl 1. A potent immunosuppressive activity found in Isaria sin- clairii metabolite. J Antibiot(Tokyo), 1994, 47:208-215.
  • 2Jeffery DR, Markowitz CE, Reder AT, et al. Fingolimod for the treatment of relapsing multiple sclerosis. Expert Rev Neurother, 2011, 11:165-183.
  • 3Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and periopheral lymphoid organs is dependent on SIP re- ceptor 1. Nature, 2004, 427:355-360.
  • 4Shah MV, Zhang R, Irby R, et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cyto- toxic lymphocytes. Blood, 2008, 112:770-781.
  • 5Dev KK, Mullershausen F, Mattes H, et al. Brain sphingosine-1- phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol Ther, 2008, 117:77-93.
  • 6Brinkmann V, Billich A, Baumruker T, et al. Fingolimod (FTY720) : discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Diseov, 2010, 9:883-897.
  • 7Zhang N, Qi Y, Wadham C, et al. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy, 2010, 6 : 1157-1167.
  • 8Tonelli F, Lim KG, Loveridge C, et al. FTY720 and (S)- FTY720 vinylphosphonate inhibit sphingosine kinase 1 and pro- mote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal, 2010, 22:1536-1542.
  • 9Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell, 2008, 132: 27-42.
  • 10Tsujimoto Y, Shimizu S. Another way to die: autophagie pro- grammed cell death. Cell Death Differ, 2005, 12 Suppl 2:1528- 1534.

共引文献20

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部